Last $56.97 USD
Change Today -0.62 / -1.08%
Volume 12.9K
IART On Other Exchanges
As of 10:18 AM 01/27/15 All times are local (Market data is delayed by at least 15 minutes).

integra lifesciences holding (IART) Snapshot

Previous Close
Day High
Day Low
52 Week High
01/26/15 - $57.81
52 Week Low
04/11/14 - $42.50
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

integra lifesciences holding (IART) Related Businessweek News

No Related Businessweek News Found

integra lifesciences holding (IART) Details

Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery. The company operates in five segments: U.S. Neurosurgery, U.S. Extremities, U.S. Instruments, U.S. Spine and Other, and International. Its orthopedics products include specialty metal implants for surgery of the extremities, shoulder, and spine; orthobiologic products for repair and grafting of bone, including demineralized bone products, collagen ceramic matrices, and synthetic bone grafting solutions; dermal regeneration products and tissue-engineered wound dressings; and nerve and tendon repair products. The company also offers spinal fusion technologies comprising integrated interbody fusion devices, minimally invasive solutions, and deformity correction products; and neurosurgery and critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. In addition, it provides extremity products, including bone and joint fixation devices, implants and instruments for osteoarthritis, rheumatoid arthritis, wrist and shoulder arthroplasty, carpal tunnel syndrome, and cubital tunnel syndrome, as well as regenerative medicine devices for the treatment of acute and chronic wounds, peripheral nerve repair and protection and tendon repair, and bone graft substitutes. Further, the company offers instruments products, such as specialty and general surgical and dental instruments; and surgical lighting for hospitals, outpatient surgery centers, and physician, veterinarian, and dental practices. Integra LifeSciences Holdings Corporation sells its products directly through various sales forces and distribution channels in the United States and internationally. The company was founded in 1989 and is headquartered in Plainsboro, New Jersey.

3,300 Employees
Last Reported Date: 02/27/14
Founded in 1989

integra lifesciences holding (IART) Top Compensated Officers

Chief Executive Officer, President, Director ...
Total Annual Compensation: $787.1K
President of Specialty Surgical Solutions and...
Total Annual Compensation: $335.1K
Corporate Vice President, General Counsel, Ad...
Total Annual Compensation: $355.7K
Compensation as of Fiscal Year 2013.

integra lifesciences holding (IART) Key Developments

Integra LifeSciences Holdings Corporation Launches Integra Reinforcement Matrix

Integra LifeSciences Holdings Corporation announced the full market release of Integra Reinforcement Matrix, a biological implant composed of porcine dermis that may be used for any type of tendon injury that requires surgical reconstruction. Tendon injuries are some of the most common musculoskeletal disorders, ranging from a mild ankle sprain to an Achilles tendon rupture or flexor tendon injury of the hand. Integra Reinforcement Matrix has high tensile strength that provides durable reinforcement during the healing phase of a repaired tendon, and omni-directional suture pullout strength that minimizes tearing. The collagen matrix allows early cellular repopulation, remodeling and revascularization for long- term repair. The product is available in two convenient sizes, 4 cm X 7 cm and 5 cm X 10 cm, and is ready-to-use, hydrated, and does not require special handling before surgery.

Integra LifeSciences Holdings Corporation Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-14-2015 04:30 PM

Integra LifeSciences Holdings Corporation Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-14-2015 04:30 PM. Venue: Westin St. Francis Hotel, San Francisco, California, United States. Speakers: Peter J. Arduini, Chief Executive Officer, President, Director and Member of Special Award Committee.

Integra LifeSciences Holdings Corporation Launches Integra(R) Meshed Dermal Regeneration Template

Integra LifeSciences Holdings Corporation announced the expansion of its skin and wound product line with the introduction of Integra® Meshed Dermal Regeneration Template. Integra Meshed Dermal Regeneration Template has received Pre-Market Approval (PMA) from the United States Food and Drug Administration (FDA), and expects to begin a full market release in the United States in January 2015. Integra Meshed Dermal Regeneration Template is a collagen-chondroitin-6-sulfate, pre-meshed bilayer matrix indicated for the postexcisional treatment of life-threatening full-thickness or deep partial-thickness thermal injuries, and the repair of scar contractures when other therapies have failed. Terminally sterilized, Integra Meshed Dermal Regeneration Template is conveniently stored at room temperature, has a 24-month shelf life, and is intended for one-time use.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IART:US $56.97 USD -0.62

IART Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Chemed Corp $103.86 USD -0.59
CONMED Corp $47.72 USD -0.085
Globus Medical Inc $24.31 USD -0.20
Masimo Corp $26.77 USD -0.20
NuVasive Inc $46.60 USD -0.23
View Industry Companies

Industry Analysis


Industry Average

Valuation IART Industry Range
Price/Earnings 52.9x
Price/Sales 2.1x
Price/Book 2.7x
Price/Cash Flow 40.0x
TEV/Sales 1.2x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INTEGRA LIFESCIENCES HOLDING, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at